Novo Nordisk A/S Common Stock (NVO)

Other Income/Expenses (Net)

kr 6.65B

TTM · Period ending: · DKK

NVO logo

NVO Other Income/Expenses (Net)

Latest reportedkr 6.65B DKK
NVO TTM Other Income/Expenses (Net) · DKK (-kr 675.91M → kr 6.65B)
High-resolution chart · PNG

NVO other income/expenses (net) history

Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.

Novo Nordisk A/S Common Stock Other Income/Expenses (Net) — Trailing twelve months (TTM) (DKK)
Period endingOther Income/Expenses (Net) (DKK)
6,652,000,000
7,194,000,000
2,882,000,000
-747,000,000
-2,020,000,000
-2,978,000,000
-1,148,000,000
886,000,000
1,474,000,000
2,442,000,000
2,100,000,000
475,000,000
-2,827,000,000
-4,789,000,000
-5,747,000,000
-5,497,000,000
-3,482,000,000
-1,748,000,000
436,000,000
1,781,000,000
1,801,000,000
1,241,000,000
-996,000,000
-2,614,000,000
-3,309,000,000
-4,194,000,000
-3,930,000,000
-3,549,000,000
-3,412,000,000
-1,811,000,000
367,000,000
1,304,000,000
2,397,000,000
1,360,000,000
-287,000,000
-1,075,000,000
-1,612,000,000
-764,000,000
-634,000,000
-1,181,000,000
-2,906,000,000
-4,945,000,000
-5,961,000,000
-5,955,000,000
-4,226,000,000
-2,036,000,000
-396,000,000
845,000,000
1,267,000,000
1,107,000,000
1,046,000,000
490,000,000
-322,000,000
-1,128,000,000
-1,663,000,000
-1,813,000,000
-1,462,000,000
-649,000,000
-449,000,000
182,000,000
-132,000,000
-668,000,000
-605,000,000
-1,193,000,000
-932,000,000
-705,000,000
-945,000,000
-1,021,899,000
-632,899,000
-24,058,000
319,942,000
846,906,400
842,491,400
2,023,895,400
2,029,543,400
2,110,491,000
1,962,316,000
237,969,000
39,417,000
-504,197,000
-428,154,000
-288,052,000
141,723,000
667,263,000
645,591,000
669,965,000
484,724,000
-1,624,819,000
-3,345,626,000
-4,977,878,000
-4,742,240,000
9,579,861,000
4,771,219,000
1,100,617,000
-5,245,995,000
-6,127,810,000
-6,334,253,000
-6,801,449,000
-6,127,486,000
-3,338,310,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.